Increasing antiviral treatment through “four supports” strategy: A randomized multicenter trial

A randomized controlled trial study to promote antiviral therapy in patients with chronic hepatitis C

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060858

Enrollment

Unknown

Registered

2022-06-12

Start date

2022-06-01

Completion date

Unknown

Last updated

2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis C virus

Interventions

Intervention group:“Four supports” strategy

Control group:Current usual education

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Over 18 years old. 2.Chronic hepatitis C. This is defined as the documentation of the presence of circulating hepatitis C virus by a positive hepatitis C Polymerase Chain Reaction test that is compatible with chronic hepatitis. 3.Patients must not be treatment. 4.HCV patients and a family member could use a smart cellphone. 5.Patient must be able to give informed consent.

Exclusion criteria

Exclusion criteria: 1.Chronic hepatitis C patients in pregnancy or lactation. 2.HCV patients complicated with HIV or HBV. 3.Other significant near term life-threatening diseases and severe psychotic disorder.

Design outcomes

Primary

Measure	Time frame
The proportion of commencing antiviral treatment;	—

Secondary

Measure	Time frame
Sustained virologic response rates;The days from group-randomized to commencing treatment;The proportion of completing antiviral treatment;Desire of antiviral treatment;	—

Countries

China

Contacts

Public ContactZhongfu Liu

National Center for AIDS/STD Control and Prevention, China CDC

liuzhongfu@chinaaids.cn+86 010 58900909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026